ORPHAZYME A/S |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,090 DKK | -0.91% |
|
+4.11% | -18.05% |
| Mar. 27 | Orphazyme A/S Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Mar. 04 | FDA Extends Review of Zevra's Arimoclomol by Three Months | DJ |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Neutral |
| Resistance | 1,118.20 | 1,400.00 | 2,905.00 |
| Spread/Res. | -2.52% | -22.14% | -62.48% |
| Spread/Supp. | +8.46% | +61.05% | +55.71% |
| Support | 1,005.00 | 676.80 | 700.00 |
- Stock Market
- Equities
- ORPHA Stock
- Charts Orphazyme A/S
